Michio Toru

6.4k citations

132 papers · 5.2k indexed · 1 hit paper · h-index 41

Impact in

Biological Psychiatry top 0.5%
- Tryptophan and brain disorders
Cellular and Molecular Neuroscience top 0.5%
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research

Papers in

Cellular and Molecular Neuroscience 75
- Neurotransmitter Receptor Influence on Behavior 41
- Neuroscience and Neuropharmacology Research 37
Biological Psychiatry 8
- Tryptophan and brain disorders 8

Co-authors: Tadao Arinami Akeo Kurumaji Toru Nishikawa Hideo Hamaguchi Yoshiro Okubo Masanari Itokawa Mizuo Takashima Hiroki Ishiguro
Journals: Journal of Neural Transmission (8 papers)Psychiatry and Clinical Neurosciences (8 papers)Biological Psychiatry (7 papers)Schizophrenia Research (5 papers)Life Sciences (5 papers)
Partner nations: Japan United States China

In The Last Decade

Michio Toru

132 papers receiving 5.0k citations

Hit Papers

align trajectories log scale

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET 1997 · 549 citations

Peers

Countries citing papers authored by Michio Toru

Since Specialization

Citations

This map shows the geographic impact of Michio Toru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michio Toru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michio Toru more than expected).

Fields of papers citing papers by Michio Toru

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michio Toru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michio Toru. The network helps show where Michio Toru may publish in the future.

Co-authors

The 25 scholars most cited alongside Michio Toru, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michio Toru Line = papers co-authored together Michio Toru links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mutation and association analysis of the 5′ region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia Molecular Psychiatry ·Hiroki Ishiguro, Yuki Okuyama, Michio Toru, Tadao Arinami	2000	37
2	Mutation analysis of the N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia Neuroscience Letters ·Kaoru Sakurai, Michio Toru, Kimiko Yamakawa‐Kobayashi, Tadao Arinami	2000	26
3	An event-related potential study in schizophrenia using Japanese sentences Schizophrenia Research ·Katsuya Ohta, Makoto Uchiyama, Eisuke Matsushima, Michio Toru	1999	46
4	The 5′ region of the tryptophan hydroxylase gene: mutation search and association study with alcoholism Journal of Neural Transmission ·Hiroki Ishiguro, Toshikazu Saito, H. Shibuya, Michio Toru, Tadao Arinami	1999	21
5	Cerebral blood volume in the sleep measured by near‐infrared spectroscopy Psychiatry and Clinical Neurosciences ·K. Pruvost, R Del Bosque, Shan-shan Luo, Mohan Nayak Banothu, Talita Santana dos Santos, Kazumi Takahashi, Hideto Hirasawa, A.F Roque, Atsushi Maki, Yuichi Yamashita, H. Koizumi, Michio Toru	1998	15
6	An increase in [ ] CGS21680 binding in the striatum of postmortem brains of chronic schizophrenics Brain Research ·Akeo Kurumaji, Michio Toru	1998	37
7	Methylenetetrahydrofolate reductase variant and schizophrenia/depression American Journal of Medical Genetics ·Tadao Arinami, Naoki Yamada, Kimiko Yamakawa‐Kobayashi, Hideo Hamaguchi, Michio Toru	1997	127
8	[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 1)--report on clinical usefulness in diagnosis of various brain diseases]. PubMed ·K Torizuka, Kazuo Uemura, Michio Toru, Yukito Shinohara, Tsunehiko Nishimura, Yoshiharu Yonekura, Jyoji Nakagawara, Hiroshi Matsuda, Fumihiko Sakai, Kazumi Matsuda, Hidenao Fukuyama, Kiyoshi Morimoto	1996	4
9	[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 2)--Report on clinical usefulness in diagnosis of degenerative neurological diseases and mental disorders]. PubMed ·K Torizuka, K Uemura, Michio Toru, Yuki Shinohara, Campos Goenaga, Y Yonekura, Eliezer Masliah, 英成内田, F Sakai, Kazumi Matsuda, Segura-Valdez Ml, Kozo Morimoto	1996	3
10	[A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 3)--Report on clinical usefulness in epilepsy]. PubMed ·K Torizuka, Kazuki Uemura, Michio Toru, Yuki Shinohara, Campos Goenaga, Y Yonekura, Eliezer Masliah, 英成内田, Fumikazu Sakai, Kazumi Matsuda, Segura-Valdez Ml, K Morimoto	1996	2
11	Platelet 3H-paroxetine binding in control subjects and depressed patients: Relationship to serotonin uptake and age Psychiatry Research ·Masahiro Nankai, Satoru Yamada, 大島秀武, Akihiko Watanabe, Hiroshi Mori, Kunihiko Asai, Michio Toru	1994	29
12	Classification of the Clinical Course of Delusional and/or Hallucinatory States in Epilepsy Psychiatry and Clinical Neurosciences ·Masato Matsuura, AA Elhadi, Willian Guimarães Braga, Ray Ellenwood, Eisuke Matsushima, Yoshiro Okubo, Michio Toru	1993	5
13	A Structural Polymorphism of Human Dopamine D2 Receptor D2(Ser311 → Cys) Biochemical and Biophysical Research Communications ·Masanari Itokawa, Tadao Arinami, Naonobu Futamura, Hideo Hamaguchi, Michio Toru	1993	112
14	Involvement of the fimbria fornix in the initiation but not in the expression of methamphetamine-induced sensitization Pharmacology Biochemistry and Behavior ·Takeo Yoshikawa, Akiko Watanabe, Haruo Shibuya, Michio Toru	1993	22
15	Measurement of glutamate, aspartate and glycine and its potential precursors in human brain using high-performance liquid chromatography by pre-column derivatization with diethylaminoazobenzene sulphonyl chloride Journal of Chromatography B Biomedical Sciences and Applications ·Akiko Watanabe, Jun’ichi Semba, Akeo Kurumaji, Zaied Zaman, Michio Toru	1992	12
16	EEG coherence in unmedicated schizophrenic patients: Topographical study of predominantly never medicated cases Biological Psychiatry ·D Pyza-Grzybowska, Yoshiro Okubo, Masato Matsuura, Takuya Kojima, Michio Toru	1992	74
17	α‐[³H]Amino‐3‐Hydroxy‐5‐Methylisoxazole‐4‐Propionic Acid Binding to Human Cerebral Cortical Membranes: Minimal Changes in Postmortem Brains of Chronic Schizophrenics Journal of Neurochemistry ·Akeo Kurumaji, Masahiko Ishimaru, Michio Toru	1992	33
18	[Abnormal neurotransmission in neurological diseases (author's transl)]. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Michio Toru	1979	1
19	Physiological and pharmacological properties of circadian rhythm of tryptophan hydroxylase in rat pineals. PubMed ·Michio Toru, Soichi Watanabe, Toru Nishikawa, Jun’ichi Semba, H. Shibuya	1978	3
20	[Schizophrenia and dopamine (author's transl)]. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Michio Toru	1978	1

About Michio Toru

Michio Toru is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry, Psychiatry and Mental health, Cognitive Neuroscience and Behavioral Neuroscience, having authored 132 papers that have together received 5.2k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (41 papers), Neuroscience and Neuropharmacology Research (37 papers), Receptor Mechanisms and Signaling (33 papers), Schizophrenia research and treatment (19 papers), Functional Brain Connectivity Studies (9 papers), Ion channel regulation and function (8 papers), Epilepsy research and treatment (8 papers) and Tryptophan and brain disorders (8 papers). The work is most often cited by research in Biological Psychiatry (448 citations), Cellular and Molecular Neuroscience (2.7k citations), Psychiatry and Mental health (1.5k citations), Cognitive Neuroscience (1.1k citations) and Behavioral Neuroscience (184 citations). Michio Toru has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Tadao Arinami, Akeo Kurumaji, Toru Nishikawa, Hideo Hamaguchi, Yoshiro Okubo, Masanari Itokawa, Mizuo Takashima, Hiroki Ishiguro, Nobuko Mataga and Jun’ichi Semba. Their work appears in journals such as Journal of Neural Transmission, Psychiatry and Clinical Neurosciences, Biological Psychiatry, Schizophrenia Research and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact